Novabay Pharmaceuticals Inc Stock Ownership - Who owns Novabay Pharmaceuticals?

Insider buying vs selling

Have Novabay Pharmaceuticals Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when NBY insiders and whales buy or sell their stock.

NBY Shareholders

What type of owners hold Novabay Pharmaceuticals Inc stock?
Ramin Najafi291.48%19,031,699$5.61MInsider
China Pioneer Pharma Holdings Ltd223.91%14,619,468$4.31MInsider
Pioneer Pharma Hong Kong Co Ltd186.76%12,194,077$3.60MInsider
Pioneer Pharma Singapore Pte Ltd79.46%5,188,421$1.53MInsider
Jian Ping Fu61.26%4,000,000$1.18MInsider
Xinzhou Li42.91%2,801,743$826.51kInsider
Naqu Area Pioneer Pharma Co Ltd42.88%2,800,000$826.00kInsider
Mark M. Sieczkarek17.72%1,156,883$341.28kInsider
Robert R. Tufts15.58%1,017,066$300.03kInsider
Anthony Dailley14.04%917,035$270.53kInsider

1 of 3

NBY vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
IBIO2.52%97.48%Net SellingNet Selling
ATXI1.68%38.31%Net Buying

Novabay Pharmaceuticals Stock Ownership FAQ

Who owns Novabay Pharmaceuticals?

Novabay Pharmaceuticals (NYSEMKT: NBY) is owned by 3.95% institutional shareholders, 991.84% Novabay Pharmaceuticals insiders, and 0.00% retail investors. Ramin Najafi is the largest individual Novabay Pharmaceuticals shareholder, owning 19.03M shares representing 291.48% of the company. Ramin Najafi's Novabay Pharmaceuticals shares are currently valued at $5.65M.

If you're new to stock investing, here's how to buy Novabay Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.